Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.
van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, Haanen HC, Hofman DM, van Albada-Kuipers GA, ter Borg EJ, Brus HL, Dinant HJ, Kruize AA, Schenk Y. van der Heide A, et al. Among authors: van booma frankfort c, van albada kuipers ga, van der veen mj. Ann Intern Med. 1996 Apr 15;124(8):699-707. doi: 10.7326/0003-4819-124-8-199604150-00001. Ann Intern Med. 1996. PMID: 8633829 Clinical Trial.
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.
Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, Borg EJ, Hofman DM, van der Veen MJ; Utrecht Arthritis Cohort Study Group. Verstappen SM, et al. Among authors: van booma frankfort c, van der veen mj. Arthritis Rheum. 2003 Jul;48(7):1797-807. doi: 10.1002/art.11170. Arthritis Rheum. 2003. PMID: 12847672 Free article. Clinical Trial.
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, Geurts MA, van der Werf JH, van Albada-Kuipers GA, Jahangier-de Veen ZN, van der Veen MJ, Verhoef CM, Lafeber FP, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Bakker MF, et al. Among authors: van der veen mj. Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004. Ann Intern Med. 2012. PMID: 22393128 Free article. Clinical Trial.
Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.
van Jaarsveld CH, Jacobs JW, van der Veen MJ, Blaauw AA, Kruize AA, Hofman DM, Brus HL, van Albada-Kuipers GA, Heurkens AH, ter Borg EJ, Haanen HC, van Booma-Frankfort C, Schenk Y, Bijlsma JW. van Jaarsveld CH, et al. Among authors: van booma frankfort c, van albada kuipers ga, van der veen mj. Ann Rheum Dis. 2000 Jun;59(6):468-77. doi: 10.1136/ard.59.6.468. Ann Rheum Dis. 2000. PMID: 10834865 Free PMC article. Clinical Trial.
Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
van Jaarsveld CH, Jahangier ZN, Jacobs JW, Blaauw AA, van Albada-Kuipers GA, ter Borg EJ, Brus HL, Schenk Y, van Der Veen MJ, Bijlsma JW. van Jaarsveld CH, et al. Among authors: van albada kuipers ga, van der veen mj. Rheumatology (Oxford). 2000 Dec;39(12):1374-82. doi: 10.1093/rheumatology/39.12.1374. Rheumatology (Oxford). 2000. PMID: 11136881 Clinical Trial.
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).
Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, Blaauw AA, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort study group. Verstappen SM, et al. Among authors: van der veen mj. Ann Rheum Dis. 2007 Nov;66(11):1443-9. doi: 10.1136/ard.2007.071092. Epub 2007 May 22. Ann Rheum Dis. 2007. PMID: 17519278 Free PMC article. Clinical Trial.
Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
Bakker MF, Jacobs JW, Kruize AA, van der Veen MJ, van Booma-Frankfort C, Vreugdenhil SA, Bijlsma JW, Lafeber FP, Welsing PM. Bakker MF, et al. Among authors: van booma frankfort c, van der veen mj. Ann Rheum Dis. 2012 Jun;71(6):830-5. doi: 10.1136/annrheumdis-2011-146670. Epub 2011 Nov 29. Ann Rheum Dis. 2012. PMID: 22128075
51 results